The European Alliance of Associations for Rheumatology has long recognized the pivotal role of patients in the development of recommendations, and the role of patients in research is also evolving. But collaboration with ...
Jun 14, 2024
0
1
Glucocorticoids are a mainstay of treatment for systemic lupus erythematosus (SLE). But due to long-term adverse effects, dose reduction is becoming a crucial part of treat-to-target management goals. However, data regarding ...
Jun 13, 2024
0
1
Early therapeutic interventions in inflammatory rheumatic diseases have proven successful in inducing drug-free remission, and EULAR—The European Alliance of Associations for Rheumatology—recommends early intervention ...
Jun 13, 2024
0
0
The exact origin and precursor differentiation route of tissue macrophages remains controversial. At the 2024 congress of EULAR—The European Alliance of Associations for Rheumatology—new work sheds light on blood precursors ...
Jun 13, 2024
0
6
EULAR—The European Alliance of Associations for Rheumatology—has recommendations aimed at promoting health-enhancing physical activity, but despite the established benefits—and evidence supporting the efficacy of physical ...
Jun 13, 2024
0
1
VEXAS syndrome is a rare, adult-onset, life-threatening autoinflammatory disease caused by a genetic mutation. The pathophysiology is still unknown, but new work presented at the 2024 congress of EULAR—The European Alliance ...
Jun 12, 2024
0
1
Knee osteoarthritis (OA) is a common cause of pain and joint stiffness. And while physical activity is known to ease symptoms, only one in 10 people regularly exercise.
Jun 12, 2024
0
1
People with rheumatoid arthritis (RA) tend to have different trajectories—both in how the disease evolves, and how disease states may improve over time. The frequency of pain patterns at diagnosis and over time—and their ...
Jun 12, 2024
0
1
Psoriatic arthritis (PsA) is a chronic inflammatory arthritis which appears in around one-third of people with psoriasis. EULAR—The European Alliance of Associations for Rheumatology—is committed to reducing the impact ...
Jun 12, 2024
0
1
In patients with axial spondyloarthritis (axSpA) and persistent disease activity for which adapting treatment is recommended, treatment intensification should be considered for patients with persistently high disease activity. ...
Jun 12, 2024
0
42
